Assessing the Treatment of Patients With Neuropathic Pain Using LYRICA; A Non Interventional Post-marketing Study (NI-PMS).
Latest Information Update: 12 Feb 2021
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms ATLAS; NI-PMS
- Sponsors Pfizer
- 17 Apr 2009 Actual patient number amended from 700 to 691 as reported by ClinicalTrials.gov.
- 18 Feb 2009 New trial record